ArticleOphthalmology. Retina2022
Comparison of Handheld Retinal Imaging with ETDRS 7-Standard Field Photography for Diabetic Retinopathy and Diabetic Macular Edema.
Article in Ophthalmology. Retina, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.
- Diabetic Retinopathy Screening Approaches in Developing Countries: A Systematic Review and Meta-Analysis.Turkish journal of ophthalmology · 2025Pooled it
- Use of preoperative swept-source optical coherence tomography in vitrectomy for advanced diabetic eye disease: a pilot study.Frontiers in ophthalmology · 2026Article
- Performance of a Retinal Imaging Camera With On-Device Intelligence for Primary Care: Retrospective Study.JMIR formative research · 2025Article
- Integrating Nursing-Teleophthalmology Improves Diabetic Retinopathy Screening in Primary Healthcare, Reducing Unnecessary Referrals to Specialist Healthcare.International journal of nursing practice · 2025Article
- A portable retina fundus photos dataset for clinical, demographic, and diabetic retinopathy prediction.Scientific data · 2025Article
- Barriers and enablers of access to diabetes eye care in Auckland, New Zealand: a qualitative study.BMJ open · 2025Article
- A novel contrast enhancement technique for diabetic retinal image pre-processing and classification.International ophthalmology · 2024Article
- Comparison of 21 artificial intelligence algorithms in automated diabetic retinopathy screening using handheld fundus camera.Annals of medicine · 2024Article
- Two Handheld Retinograph Devices Evaluated by Ophthalmologists and an Artificial Intelligence Algorithm.Journal of clinical medicine · 2024Article
- Modern Approach to Diabetic Retinopathy Diagnostics.Diagnostics (Basel, Switzerland) · 2024Review
- Image quality comparison of AirDoc portable retina camera versus eyer in a diabetic retinopathy screening program.International journal of retina and vitreous · 2024Article
- One-field, two-field and five-field handheld retinal imaging compared with standard seven-field Early Treatment Diabetic Retinopathy Study photography for diabetic retinopathy screening.The British journal of ophthalmology · 2024Article
- Comparison of 50° handheld fundus camera versus ultra-widefield table-top fundus camera for diabetic retinopathy detection and grading.Eye (London, England) · 2023Article
- Comparisons of handheld retinal imaging devices with ultrawide field images for determining diabetic retinopathy severity.Acta ophthalmologica · 2023Article
- Clinical validation of a smartphone-based retinal camera for diabetic retinopathy screening.Acta diabetologica · 2023Article
- Building a new regional home for implementation science: Annual Midwest Clinical & Translational Research Meetings.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2023Article
- Single retinal image for diabetic retinopathy screening: performance of a handheld device with embedded artificial intelligence.International journal of retina and vitreous · 2023Article
- Comparisons of Handheld Retinal Imaging with Optical Coherence Tomography for the Identification of Macular Pathology in Patients with Diabetes.Ophthalmic research · 2023Article
- Comparison of 2-Field and 5-Field Mydriatic Handheld Retinal Imaging in a Community-Based Diabetic Retinopathy Screening Program.Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde · 2023Article
- Accuracy of Integrated Artificial Intelligence Grading Using Handheld Retinal Imaging in a Community Diabetic Eye Screening Program.Ophthalmology scienceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 3 countries.
Funding
Abstract
purposeTo compare nonmydriatic (NM) and mydriatic (MD) handheld retinal imaging with standard ETDRS 7-field color fundus photography (ETDRS photographs) for the assessment of diabetic retinopathy (DR) and diabetic macular edema (DME).
designProspective, comparative, instrument validation study. SUBJECTS: A total of 225 eyes from 116 patients with diabetes mellitus.
methodsFollowing a standardized protocol, NM and MD images were acquired using handheld retinal cameras (NM images: Aurora, Smartscope, and RetinaVue-700; MD images: Aurora, Smartscope, RetinaVue-700, and iNview) and dilated ETDRS photographs. Grading was performed at a centralized reading center using the International Clinical Classification for DR and DME. Kappa statistics (simple [K], weighted [Kw]) assessed the level of agreement for DR and DME. Sensitivity and specificity were calculated for any DR, referable DR (refDR), and vision-threatening DR (vtDR).
main outcome measuresAgreement for DR and DME; sensitivity and specificity for any DR, refDR, and vtDR; ungradable rates.
resultsSeverity by ETDRS photographs: no DR, 33.3%; mild nonproliferative DR, 20.4%; moderate DR, 14.2%; severe DR, 11.6%; proliferative DR, 20.4%; no DME, 68.0%; DME, 9.3%; non-center involving clinically significant DME, 4.9%; center-involving clinically significant DME, 12.4%; and ungradable, 5.3%. For NM handheld retinal imaging, Kw was 0.70 to 0.73 for DR and 0.76 to 0.83 for DME. For MD handheld retinal imaging, Kw was 0.68 to 0.75 for DR and 0.77 to 0.91 for DME. Thresholds for sensitivity (0.80) and specificity (0.95) were met by NM images acquired using Smartscope and MD images acquired using Aurora and RetinaVue-700 cameras for any DR and by MD images acquired using Aurora and RetinaVue-700 cameras for refDR. Thresholds for sensitivity and specificity were met by MD images acquired using Aurora and RetinaVue-700 for DME. Nonmydriatic and MD ungradable rates for DR were 15.1% to 38.3% and 0% to 33.8%, respectively.
conclusionsFollowing standardized protocols, NM and MD handheld retinal imaging devices have substantial agreement levels for DR and DME. With mydriasis, not all handheld retinal imaging devices meet standards for sensitivity and specificity in identifying any DR and refDR. None of the handheld devices met the established 95% specificity for vtDR, suggesting that lower referral thresholds should be used if handheld devices must be utilized. When using handheld devices, the ungradable rate is significantly reduced with mydriasis and DME sensitivity thresholds are only achieved following dilation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.